文献速递小儿眼科与斜弱视白内障与屈光手术

幼儿期人工晶状体植入:美国眼科学会报告

Intraocular Lens Implantation during Early Childhood: A Report by the American Academy of Ophthalmology.
PubMed 文献 · Ophthalmology · 2019-06-21

本报告由美国眼科学会基于2019年2月文献检索(194篇引用,34篇全文review,14篇纳入)比较≤2岁白内障术后人工晶状体(IOL)、接触镜或眼镜的视觉结局与不良事件。IOL视觉结局与接触镜或眼镜相似,但视觉轴混浊风险增加;6个月以下婴儿IOL植入后出现大幅近视漂移。结论不推荐≤6个月婴儿IOL植入,>6个月可安全进行但需考虑屈光误差和术者经验。

要点

  • ≤2岁白内障术后,IOL与接触镜或眼镜的视觉结局相似。
  • IOL与视觉轴混浊风险增加相关,6个月以下婴儿不推荐IOL植入。
  • 6个月以上儿童IOL植入可安全进行且副作用可接受,但需考虑屈光误差和术者经验。

核心结论

  • 不推荐6个月及以下儿童进行IOL植入,因为与无晶状体眼相比该治疗视觉轴混浊发生率更高。
  • 现有最佳证据表明,6个月以上儿童IOL植入可安全进行且副作用可接受。
  • 眼轴增长不可预测意味着这些儿童童年后期常出现大幅屈光误差,可能需要IOL置换或佩戴大幅屈光矫正的眼镜或接触镜。
  • 决定IOL植入是否合适时,应考虑术者的培训与经验以及眼部和全身合并症。

研究设计与样本

  • 美国眼科学会报告,文献检索于2019年2月在PubMed、Cochrane图书馆和临床试验数据库进行,无日期或语言限制。
  • 检索得到194篇可能相关引用,34篇选为全文review,14篇判定与评估标准相关并纳入本评估。
  • 专家方法学家对这些研究进行了证据等级评定。

主要发现

  • 对于双侧和单侧白内障儿童,IOL的视觉结局与接触镜或眼镜相似。
  • IOL与视觉轴混浊风险增加相关。
  • 所有治疗的青光眼发生率相似。
  • 所有治疗的眼球增长相似,但6个月以下接受IOL植入的婴儿出现大幅近视漂移,常导致童年后期高度近视或严重屈光参差。
  • 接受IOL植入的眼角膜内皮细胞计数较低。

临床怎么用

  • 不推荐6个月及以下儿童进行IOL植入(原文结论)。
  • 6个月以上儿童IOL植入可安全进行且副作用可接受(原文结论)。
  • 决定IOL植入是否合适时,应考虑术者的培训与经验以及眼部和全身合并症(原文结论)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the visual outcomes and adverse events associated with optical correction using an intraocular lens (IOL), contact lenses, or spectacles after cataract surgery in children 2 years of age or younger. METHODS: Literature searches were conducted in PubMed, the Cochrane Library, and the databases of clinical trials in February 2019, without date or language restrictions. The search resulted in 194 potentially relevant citations, and 34 were selected for full-text review. Fourteen studies were determined to be relevant to the assessment criteria and were selected for inclusion in this assessment. The panel methodologist then assigned a level of evidence rating to these studies. RESULTS: Intraocular lenses were associated with visual outcomes similar to outcomes for contact lenses or spectacles for children who had both bilateral and unilateral cataracts. Intraocular lenses were also associated with an increased risk of visual axis opacities. All treatments were associated with a similar incidence of glaucoma. Although ocular growth was similar for all treatments, infants younger than 6 months who underwent IOL implantation had large myopic shifts that often resulted in high myopia or severe anisometropia later in childhood. Corneal endothelial cell counts were lower in eyes that underwent IOL implantation. The incidence of strabismus was similar with all treatments. CONCLUSIONS: Intraocular lens implantation is not recommended for children 6 months of age or younger because there is a higher incidence of visual axis opacities with this treatment compared with aphakia. The best available evidence suggests that IOL implantation can be done safely with acceptable side effects in children older than 6 months of age. However, the unpredictability of ocular growth means that these children will often have large refractive errors later in childhood that may necessitate an IOL exchange or wearing spectacles or contact lenses with a large refractive correction. In addition, the training and experience of the surgeon as well as ocular and systemic comorbidities should be taken into consideration when deciding whether IOL implantation would be appropriate.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Lambert SR, Aakalu VK, Hutchinson AK, et al. Intraocular Lens Implantation during Early Childhood: A Report by the American Academy of Ophthalmology. Ophthalmology. 2019. PMID: 31230794. doi:10.1016/j.ophtha.2019.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。